City of London Investment Group “growth was still almost 30%” says Hardman & Co (LON:CLIG) 6 August 2021
Cizzle Biotechnology looking to adapt ELISA assay into being a more general screening tool (LON:CIZ) 2 August 2021
Fidelity Japan Trust outperforming UK markets and Japanese benchmarks says Hardman & Co (LON:FJV) 27 July 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Cranswick PLC (CWK.L) Stock Analysis: Exploring a 14.75% Potential Upside in the Defensive Food Sector 21 January 2026
Computacenter PLC (CCC.L) Stock Analysis: Navigating a 4.27% Upside Potential with Robust Growth and Dividend Appeal 21 January 2026
Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unlocking a 28.75% Potential Upside with Strong Buy Ratings 21 January 2026
Coats Group PLC (COA.L) Stock Analysis: Unpacking a 40.78% Potential Upside for Investors 21 January 2026
City of London Investment Group “growth was still almost 30%” says Hardman & Co (LON:CLIG) 6 August 2021
Cizzle Biotechnology looking to adapt ELISA assay into being a more general screening tool (LON:CIZ) 2 August 2021
Fidelity Japan Trust outperforming UK markets and Japanese benchmarks says Hardman & Co (LON:FJV) 27 July 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Cranswick PLC (CWK.L) Stock Analysis: Exploring a 14.75% Potential Upside in the Defensive Food Sector 21 January 2026
Computacenter PLC (CCC.L) Stock Analysis: Navigating a 4.27% Upside Potential with Robust Growth and Dividend Appeal 21 January 2026
Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unlocking a 28.75% Potential Upside with Strong Buy Ratings 21 January 2026
Coats Group PLC (COA.L) Stock Analysis: Unpacking a 40.78% Potential Upside for Investors 21 January 2026
Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals a 52.89% Potential Upside 16 December 2025
Evotec SE (EVO) Stock Analysis: Exploring an 87.54% Potential Upside Amid Challenging Metrics 16 December 2025
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unveiling a Potential 170% Upside in Biotech 16 December 2025
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating Growth Challenges with Innovation 16 December 2025
Omnicell, Inc. (OMCL) Stock Analysis: Exploring a Potential 19% Upside in the Healthcare Sector 16 December 2025
Arcellx, Inc. (ACLX) Investor Outlook: Exploring a Promising 65.53% Upside Potential in Biotechnology 16 December 2025
Warby Parker Inc. (WRBY) Stock Analysis: A Closer Look at its 15.2% Revenue Growth and Market Position 16 December 2025
Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 15% Upside for Forward-Thinking Investors 16 December 2025
Certara, Inc. (CERT) Stock Analysis: A 47% Upside Potential Awaits in the Healthcare Sector 16 December 2025
Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a 77% Potential Upside in Biotech 16 December 2025
Celldex Therapeutics (CLDX) Stock Analysis: Exploring the 96% Potential Upside in Biotechnology 16 December 2025
Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Exploring a Promising 31.68% Upside Potential 16 December 2025
Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Uncovering a 46% Potential Upside in the Biotech Sphere 16 December 2025
Ligand Pharmaceuticals (LGND) Stock Analysis: Unveiling a 26% Potential Upside in the Biotech Sector 16 December 2025
National HealthCare Corporation (NHC) Stock Analysis: Exploring the Healthcare Giant’s Solid Revenue Growth and Dividend Reliability 16 December 2025
Progyny, Inc. (PGNY): Investor Outlook Reveals 11.62% Potential Upside in the Healthcare Sector 16 December 2025
Mesoblast Limited (MESO) Stock Analysis: Exploring a Potential 97.63% Upside in Regenerative Medicine 16 December 2025
Arcutis Biotherapeutics, Inc. (ARQT) Stock Report: Exploring a 9.24% Potential Upside Amid Robust Growth 16 December 2025
Enovis Corporation (ENOV) Stock Analysis: Exploring an 81% Upside Potential in the Medical Device Sector 16 December 2025
Haemonetics Corporation (HAE) Stock Analysis: 12% Upside Potential Amidst Healthcare Innovations 16 December 2025
LSL Property Services very strong set of results in a very strong market (Analyst Interview) 11 August 2021
Marshall Motor Holdings Exceptional performance due to unprecedented market conditions 10 August 2021
City of London Investment Group “growth was still almost 30%” says Hardman & Co (LON:CLIG) 6 August 2021
Cizzle Biotechnology looking to adapt ELISA assay into being a more general screening tool (LON:CIZ) 2 August 2021
Fidelity Japan Trust outperforming UK markets and Japanese benchmarks says Hardman & Co (LON:FJV) 27 July 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Cranswick PLC (CWK.L) Stock Analysis: Exploring a 14.75% Potential Upside in the Defensive Food Sector 21 January 2026
Computacenter PLC (CCC.L) Stock Analysis: Navigating a 4.27% Upside Potential with Robust Growth and Dividend Appeal 21 January 2026
Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unlocking a 28.75% Potential Upside with Strong Buy Ratings 21 January 2026
Coats Group PLC (COA.L) Stock Analysis: Unpacking a 40.78% Potential Upside for Investors 21 January 2026
